MICHAEL W BONNEY Insider Trading $ALNY ALNYLAM PHARMACEUTICALS, INC.
Get free email notifications about insider trading for MICHAEL W BONNEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL W BONNEY. MICHAEL W BONNEY is Director in BRISTOL MYERS SQUIBB CO ($BMY) and in CELGENE CORP /DE/ ($CELG) and Director in CELGENE CORP /DE/ ($CELG) and Director in NPS PHARMACEUTICALS INC ($NPSP) and Chief Executive Officer in CUBIST PHARMACEUTICALS INC ($CBST) and President & CEO in CUBIST PHARMACEUTICALS INC ($CBST) and President and CEO in CUBIST PHARMACEUTICALS INC ($CBST) and Director in Sarepta Therapeutics, Inc. ($SRPT) and Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Global Blood Therapeutics, Inc. ($GBT) and Director in Tekla World Healthcare Fund ($THW) and Director in Magenta Therapeutics, Inc. ($MGTA) and Director in Kaleido Biosciences, Inc. ($KLDO) and Executive Chair in Kaleido Biosciences, Inc. ($KLDO).
MICHAEL W BONNEY in ALNYLAM PHARMACEUTICALS, INC.
Trading Symbol: ALNYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W BONNEY: Director
Holdings: 4,000 shares
Current Value: $161,840
Latest Transaction: Jul 06 2020
$ALNY Market Capitalization: $3.49B
$ALNY Previous Close: $40.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL W BONNEY in ALNYLAM PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNY, BMY, CELG, CBST, GBT, KLDO, MGTA, NPSP, SRPT, SYRS, THW
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
Mar 10 2016 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Buy | P | 58.36 | 2,000 | 116,720 | 4,000 | 2 K to 4 K (+100.00 %) |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 | |
May 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Buy | P | 112.16 | 2,000 | 224,320 | 2,000 | 0 to 2 K |
Page: 1